Good Genes Gone Bad Titelbild

Good Genes Gone Bad

A Short History of Vaccines and Biologics: Failures, Successes, Controversies

 Reinhören
Zeitlich begrenztes Angebot

3 Monate Audible Standard kostenlos testen

3 Monate Audible Standard kostenlos testen, danach 6,99 €/Monat. Monatlich kündbar.
Jetzt abonnieren
Das Angebot endet am 15. Juli 2026 23:59 Uhr. Dieses Angebot sichern!
Weitere Angebote

Good Genes Gone Bad

Von: Narendra Chirmule
Gesprochen von: Mishal Varma
Jetzt abonnieren

3 Monate Audible Standard für 0,99 €/Monat, danach 6,99 €/Monat. Monatlich kündbar. Angebot gültig bis zum 15. Juli 2026 um 23:59 Uhr.

Für 14,73 € kaufen

Für 14,73 € kaufen

The field of biotechnology has evolved over the past four decades, developing medicines which are curing diseases. But this journey of success has been tough and arduous, built upon the shoulders of major failures. Good Genes Gone Bad highlights seven such colossal failures in drug development-all of which culminated in the development of novel drugs-weaving together various analogies through the stories and thus allowing the reader to understand complex biological phenomena. These stories include treatment of medical conditions such as genetic clotting disorder (haemophilia), childhood-diarrhoea (rotavirus vaccine), preventing HIV infection, activation of the immune systems to treat cancer, gene therapy for treatment of diseases caused by gene-defects/mutations, cell therapy for treatment of leukaemias, and finally the success of Biocon's approval of the first biologic drug for breast cancer. Written by the former R&D head of Biocon, India's largest pharmaceutical company, Good Genes Gone Bad is a fascinating look at the complex world of medicine and drug development, providing the readers with a sense of magnitude of challenges and the extent of difficulty that it takes to make novel medicines. Wissenschaft
adbl_web_anon_alc_button_suppression_t1
Noch keine Rezensionen vorhanden